Should DCGI (Drug Controller General of India) take back febuxostat drug from the market?

By  Dr. KK Aggarwal

Written By: user Dr. KK Aggarwal
Published On: 21 Nov, 2021 10:26 PM | Updated On: 21 Nov, 2024 3:45 PM

Should DCGI (Drug Controller General of India) take back febuxostat drug from the market?

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will talk on the topic whether DCGI (Drug Controller General of India) should withdraw febuxostat from the market in this video. Febuxostat is given to reduce uric acid in the body. It is often misused drug in our country. If the uric acid levels are more than 10 and patient is asymptomatic then no need to treat them. High uric acid is the indicator of metabolic syndrome. It is been rejected twice by USFDA stating that it causes cardiovascular complications.

user
Dr. KK Aggarwal

Recipient of Padma Shri, Vishwa Hindi Samman, National Science Communication Award and Dr B C Roy National Award, Dr Aggarwal is a physician, cardiologist, spiritual writer and motivational speaker. He was the Past President of the Indian Medical Association and President of Heart Care Foundation of India. He was also the Editor in Chief of the IJCP Group, Medtalks and eMediNexus

 More FAQs by Dr. KK Aggarwal
बच्चों को मिलेगी कोवैक्सिन | Vaccine For Children in Hindi

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

कोरोना के दो नए टीके और गोली के बारे में सब जाने | Medtalks

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

Eating Disorders : क्‍या है ईटिंग डिसऑर्डर? जानें इसके कारण, लक्षण और बचाव के उपाय

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

ब्रेन कैंसर के लक्षण और उपचार | Brain Cancer Symptoms and Treatment in Hindi

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

हृदय रोग – प्रकार, लक्षण, कारण और बचाव |Heart Disease in Hindi

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

सेक्स से जुड़ी इन बीमारियों के बारे में नहीं जानते होंगे आप | Sex Problem in Hindi

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

एलर्जी के लक्षण, कारण, प्रकार और बचाव | Allergy in Hindi

Dr. K K Aggarwal, President Heart Care Foundation of India and Group Editor in Chief MEDtalks, will ..

Please login to comment on this article

Recent FAQs

Should DCGI (Drug Controller General of India) take back febuxostat drug from the market?
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Quick Links

Useful Links

Medbytes FAQ
About Us
Medtalks TV
Contact Us
Webinars
Privacy Policy
CMEs
Terms And Conditions
Conferences

Connect With Us